PROK

ProKidneyD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

PROK vs peer average

25/100

PROK vs. peer average (D vs. B)

Grade spread

A 2 · B 2 · C 4 · D 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

PRTA is the first available peer comparator.

Another loose development-stage biotech comp where valuation is driven more by trial/regulatory milestones than current revenue, useful for risk appetite comparison rather than mechanism overlap.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerPRTAProthena

PROK

ProKidney

PRTA

Prothena

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs PRTA

PROK / PRTA

Grade Position

Below peers

PROK vs. peer average (D vs. B)

25/100

Momentum

PROK

Value

PROK

Sentiment

PRTA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs PROK

PRTA

60/100

-1

OVID

80/100

-2

AGMB

N/A

GYRE

Gyre Therapeutics Inc Common

100/100

-3

ARVN

Arvinas Inc Common

80/100

-2

PRTA is the first peer returned for this comparison set.